- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Rituximab – March 2017
Rituximab: Solution for subcutaneous injection 1600 mg in 13.4 mL; MabThera SC®
Last updated
30 June 2017